Zacks Investment ResearchTue, 23 Jun 2026 14:45:53 GMTStrength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?FDMT+1.94%
Seeking AlphaWed, 10 Jun 2026 04:22:09 GMT4D Molecular Therapeutics, Inc. (FDMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptFDMT+1.94%
Seeking AlphaFri, 05 Jun 2026 21:52:55 GMT4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 TranscriptFDMT+1.94%
Seeking AlphaFri, 22 May 2026 22:30:44 GMT4D Molecular Therapeutics, Inc. (FDMT) Presents at RBC Capital Markets Global Healthcare Conference 2026 TranscriptFDMT+1.94%
MarketBeatSun, 17 May 2026 00:03:40 GMT4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene TherapyFDMT+1.94%
Seeking AlphaWed, 13 May 2026 23:40:44 GMT4D Molecular Therapeutics, Inc. (FDMT) Presents at Bank of America Global Healthcare Conference 2026 TranscriptFDMT+1.94%
Zacks Investment ResearchFri, 08 May 2026 00:11:50 GMT4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue EstimatesFDMT+1.94%